홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

4-Toluenesulfonyl chloride → 8-bromo-10-tosyl-2,3,5,10,11,11a-hexahydro-1H-indolizino[7,6-b]indole

HRID 1918485
인쇄

반응식

HRID 1918485 반응식
[Br:1][C:2]1[CH:10]=[C:9]2[C:5]([C:6]3[CH2:17][N:16]4[CH:12]([CH2:13][CH2:14][CH2:15]4)[CH2:11][C:7]=3[NH:8]2)=[CH:4][CH:3]=1.[H-].[Na+].[S:20](Cl)([C:23]1[CH:29]=[CH:28][C:26]([CH3:27])=[CH:25][CH:24]=1)(=[O:22])=[O:21]>C1COCC1>[Br:1][C:2]1[CH:10]=[C:9]2[C:5]([C:6]3[CH2:17][N:16]4[CH:12]([CH2:13][CH2:14][CH2:15]4)[CH2:11][C:7]=3[N:8]2[S:20]([C:23]2[CH:29]=[CH:28][C:26]([CH3:27])=[CH:25][CH:24]=2)(=[O:22])=[O:21])=[CH:4][CH:3]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 3

HCID 73974-Toluenesulfonyl chlorideHCID 24758Sodium hydrideHCID 580923028-bromo-2,3,5,10,11,11a-hexahydro-1H-indolizino[7,6-b]indole

생성물 1

HCID 666033078-bromo-10-tosyl-2,3,5,10,11,11a-hexahydro-1H-indolizino[7,6-b]indole수율 48%

시약·촉매·용매 1

HCID 8028Tetrahydrofuran용매

실험 절차

A solution of 8-Bromo-2,3,5,10,11,11a-hexahydro-1H-indolizino[7,6-b]indole (150 mg, 0.52 mmol) in THF (3 mL) was treated sequentially with NaH (31 mg, 0.77 mmol) and TsCl (0.12 g, 0.61 mmol). The reaction mixture was stirred at room temperature under argon overnight. After the mixture was concentrated, the residue was purified by flash column chromatography (silica gel, 5% CH3OH in CH2Cl2) to give 8-bromo-10-tosyl-2,3,5,10,11,11a-hexahydro-1H-indolizino[7,6-b]indole (0.11 g, 48%) as a yellow solid. 8-bromo-10-tosyl-2,3,5,10,11,11a-hexahydro-1H-indolizino[7,6-b]indole (0.11 g, 0.22 mmol) was reacted according to the procedure of Example 2 (step b) to give a yellow solid in 40% (50 mg). The yellow solid was dissolved in CH2Cl2, and NaOH (177 mg, 4.43 mmol) was added. The reaction mixture was stirred at room temperature under argon for 3 h. After the mixture was concentrated, the residue was purified by flash column chromatography (silica gel, 10% CH3OH in CH2Cl2) to give a white solid (30 mg, 83%). The white solid was dissolved in CH3OH (1 mL) and was treated with 2 N HCl in Et2O (1 mL). The resulting solid was isolated by filtration and dried under vacuum to give the title compound (30 mg, 92%) as an off-white powder: mp 270-273° C.; 1H NMR (500 MHz, CD3OD) δ 7.61 (d, J=8.0 Hz, 1H), 7.57 (d, J=8.0 Hz, 1H), 7.47-7.31 (m, 6H), 7.04 (dd, J=8.5, 2.0 Hz, 1H), 6.36-6.34 (m, 1H), 6.16 (d, J=2.5 Hz, 1H), 5.20 (s, 2H), 4.89 (d, J=14.0 Hz, 1H), 4.36 (d, J=14.0 Hz, 1H), 3.90-3.85 (m, 2H), 3.49-3.36 (m, 2H), 3.10 (dd, J=15.5, 11.0 Hz, 1H), 2.60-2.55 (m, 1H), 2.36-2.21 (m, 2H), 1.96-1.92 (m, 1H); ESI MS m/z 412 [M+H]+; HPLC (Method A)>99% (AUC), tR=12.7 min.

후처리

  1. concentrationAfter the mixture was concentrated
  2. customthe residue was purified by flash column chromatography (silica gel, 5% CH3OH in CH2Cl2)

출처 및 근거

ORD 기록
ord-b5f1b29e39014adcb5d3e42e8fd98d44
출처 데이터셋
uspto-grants-2013_12
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08618299B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트